Source: PubMed Central
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist that acts on the central nervous system to stimulate sexual arousal. The article reviews preclinical and early human studies demonstrating its ability to enhance erectile and sexual response through neurological pathways rather than vascular mechanisms.
